A detailed history of Carson Advisory Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Carson Advisory Inc. holds 24,129 shares of PFE stock, worth $598,399. This represents 0.46% of its overall portfolio holdings.

Number of Shares
24,129
Previous 25,405 5.02%
Holding current value
$598,399
Previous $710,000 1.69%
% of portfolio
0.46%
Previous 0.52%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$27.7 - $31.39 $35,345 - $40,053
-1,276 Reduced 5.02%
24,129 $698,000
Q2 2024

Aug 07, 2024

BUY
$25.26 - $29.6 $180,962 - $212,054
7,164 Added 39.27%
25,405 $710,000
Q1 2024

May 03, 2024

SELL
$25.89 - $29.73 $44,479 - $51,076
-1,718 Reduced 8.61%
18,241 $506,000
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $102,168 - $132,705
-3,910 Reduced 16.38%
19,959 $574,000
Q3 2023

Nov 08, 2023

SELL
$32.09 - $37.51 $10,750 - $12,565
-335 Reduced 1.38%
23,869 $791,000
Q2 2023

Jul 28, 2023

BUY
$36.12 - $41.79 $646,800 - $748,333
17,907 Added 284.37%
24,204 $887,000
Q2 2023

Jul 27, 2023

SELL
$36.12 - $41.79 $651,424 - $753,682
-18,035 Reduced 74.12%
6,297 $230,000
Q1 2023

May 05, 2023

SELL
$39.39 - $51.28 $84,491 - $109,995
-2,145 Reduced 8.1%
24,332 $992,000
Q4 2022

Feb 08, 2023

BUY
$41.75 - $54.5 $48,054 - $62,729
1,151 Added 4.54%
26,477 $1.36 Million
Q3 2022

Nov 07, 2022

BUY
$43.76 - $53.42 $37,633 - $45,941
860 Added 3.52%
25,326 $1.11 Million
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $76,774 - $91,030
1,650 Added 7.23%
24,466 $1.28 Million
Q1 2022

May 03, 2022

SELL
$45.75 - $56.69 $43,782 - $54,252
-957 Reduced 4.03%
22,816 $1.18 Million
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $982,300 - $1.46 Million
23,773 New
23,773 $1.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $139B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Carson Advisory Inc. Portfolio

Follow Carson Advisory Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carson Advisory Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carson Advisory Inc. with notifications on news.